Tag: Johnson & Johnson

With an exceptional track record of 28 years in the industry, Anuj brings extensive healthcare experience and a strategic patient-centric vision to lead the company's operations

To bring quality cancer treatment closer to patients, India’s leading MedTech brand is joining forces with the unique technology-led platform

Leading biopharmaceutical scientists and industry leaders shared their valuable insights at the e-Conference on ‘Digital Laboratories: The Emerging Era of High-Tech R&D’ organized by BioVoice News on March 30, 2022

Corporate TB Pledge is a joint initiative between Central TB Division, Ministry of Health and Family Welfare and USAID. #BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers

mRNA vaccines have been possible because we digitized the genomic information from the virus itself, stated Alex Gorsky, Executive Chairman, Johnson & Johnson.................

The union health ministry has clarified that the Bedaquiline which is used in selective cases, is available only through Revised National TB Control Programme (RNTCP) and open market sale of the drug is not permitted in India as of now...…………..

The company's annual 'Health for Humanity' report discloses progress on global commitments and highlights key achievements toward eradicating and preventing disease, reimagining care delivery and promoting lifelong health................

GlobalData anticipates ample opportunities for therapies targeting the skin microbiome as there are only three pipeline therapies in clinical development................

The latest failure of three anti-obesity drugs to provide the anticipated results could lead to the companies taking a cautious approach while investing to develop further drugs in the area.............

The 4th HITLAB Innovators Summit held on February 10 at the Indian Institute of Technology, Delhi featured speakers from leading organizations including Johnson & Johnson, Stryker, IBM, PATH, Terumo, and more............................